Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901

Jemal, 2006, Cancer statistics, 2006, CA Cancer J Clin, 56, 106, 10.3322/canjclin.56.2.106 Govindan, 2006, Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database, J Clin Oncol, 24, 4539, 10.1200/JCO.2005.04.4859 Pignon, 2002, A meta-analysis of thoracic radiotherapy for small-cell lung cancer, N Engl J Med, 327, 1618, 10.1056/NEJM199212033272302 Auperin, 1999, Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group, N Engl J Med, 341, 476, 10.1056/NEJM199908123410703 Schiller, 2001, Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593—a phase III trial of the Eastern Cooperative Oncology Group, J Clin Oncol, 19, 2114, 10.1200/JCO.2001.19.8.2114 Hanna, 2002, Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study, Ann Oncol, 13, 95, 10.1093/annonc/mdf014 Noda, 2002, Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer, N Engl J Med, 346, 85, 10.1056/NEJMoa003034 Hanna, 2006, Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer, J Clin Oncol, 24, 2038, 10.1200/JCO.2005.04.8595 Kirsching, 1999, Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group, Am J Clin Oncol, 22, 517, 10.1097/00000421-199910000-00019 Ettinger, 1995, Phase II study of paclitaxel in patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group study, J Clin Oncol, 13, 1430, 10.1200/JCO.1995.13.6.1430 Smit, 1995, Phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer, Br J Cancer, 77, 347, 10.1038/bjc.1998.54 Yamamoto, 2006, Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer, Anticancer Res, 26, 777 Fennelly, 1997, Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer, J Clin Oncol, 15, 187, 10.1200/JCO.1997.15.1.187 Seidman, 1998, Dose-dense therapy with weekly 1-hour paclitaxel infusion in the treatment of metastatic breast cancer, J Clin Oncol, 16, 3353, 10.1200/JCO.1998.16.10.3353 Chang, 2001, Weekly paclitaxel in advanced non-small cell lung cancer, Semin Oncol, 28, 10, 10.1053/sonc.2001.27607 Akerley, 1998, Phase I trial of weekly paclitaxel in advanced lung cancer, J Clin Oncol, 16, 153, 10.1200/JCO.1998.16.1.153 Akerley, 2003, Weekly, high-dose paclitaxel in advanced lung carcinoma: a Phase II study with pharmacokinetics by the Cancer and Leukemia Group B, Cancer, 97, 2480, 10.1002/cncr.11375 Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors, J Natl Cancer Inst, 92, 205, 10.1093/jnci/92.3.205 Kaplan, 1985, Non-parametric estimation from incomplete observation, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Groen, 1999, Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross resistant schedule, J Clin Oncol, 17, 927, 10.1200/JCO.1999.17.3.927 Kakolyris, 2001, Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II study, Ann Oncol, 12, 193, 10.1023/A:1008322932251 Sonpavde, 2000, Phase II study of doxorubicin and paclitaxel as second-line chemotherapy of small-cell lung cancer: a Hoosier Oncology Group Trial, Am J Clin Oncol, 23, 68, 10.1097/00000421-200002000-00019 Neill, 2005, Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B trial 9732, J Clin Oncol, 23, 3752, 10.1200/JCO.2005.09.071 Mavroudis, 2001, A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer, Ann Oncol, 12, 463, 10.1023/A:1011131303391 Seidman, 2005, Proc Am Soc Clin Oncol, 22, 6S